Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors

NCT02828098 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Part 1: BO-112
DRUG: Part 2: BO-112

Sponsor

Highlight Therapeutics

Collaborators

[object Object]